US Generic Drugs from History to the Future

​Please join us for our upcoming RxConnectIL event on May 14th at 8:00 PM.

​We’re pleased to host Adi Kleiman from CooperSurgical, who will lead us through a fascinating session on:
“US Generic Drugs from History to the Future” and the critical role of generic pharmaceuticals in the American healthcare system.

​About the session:

​Generic drugs represent the backbone of affordable healthcare in America, comprising 90% of all prescriptions dispensed while generating $445 billion in annual savings for patients and payers.

​We will examine how landmark legislation like the 1984 Hatch-Waxman Act transformed the pharmaceutical landscape, the complex regulatory approval process through FDA's Abbreviated New Drug Application (ANDA) pathway, and the intricate supply chain dynamics that determine drug pricing and availability.

​Join us to discover the current challenges facing the industry, including supply chain vulnerabilities and market consolidation, and explore emerging trends in complex generics and biosimilars that will shape the future of affordable medication access.

​

​About the Speaker

​Adi has over 20 years of experience in the pharma industry, with a focus on production and supply chain. Specifically in the generics sector, for 15+ years, Adi has led initiatives from new product selection to successful market launches.

​

​Looking forward seeing you,

​Galit, Michal and Adi

​The donation is optional.